DARODIPINE
UNII N4AL7X96GL

Substance Identification & Data

This profile provides standardized clinical and technical data for Darodipine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N4AL7X96GL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 72803-02-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N4AL7X96GL

CAS Registry Number

72803-02-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARODIPINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H21N3O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QERUYFVNIOLCHV-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174738

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

51701

Unique identification number in the NCBI database of chemical substances.

INN ID

5307

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

X-29

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C=1(C(C(C(=O)OCC)=C(NC1C)C)c2c3c(non3)ccc2)C(=O)OCC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Darodipine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.